HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma.

Abstract
Lung cancer is the leading cause of cancer death around the world. Adenocarcinoma is the most common histological type and has various histologic subtypes: lepidic, acinar, papillary, solid, and invasive mucinous adenocarcinoma. Histologic subtypes are related to invasiveness of tumors; eg, lepidic subtype is less invasive than acinar/papillary subtype. HTR3A is the main subunit of 5-hydroxytryptamine 3 (5-HT3) receptors, which are the only ligand-gated ion channels in seven families of 5-HT receptors. Although 5-HT3 receptor is expressed mainly throughout the central and peripheral nervous systems, some papers report the effect of 5-HT3 receptors on tumor cells, including lung cancer. However, whether HTR3A correlates with histopathological findings such as the histologic subtypes or the distribution in an individual sample remains unclear. Immunohistochemically, we revealed that the higher expression level of HTR3A was detected in acinar, papillary, and solid adenocarcinoma than in adenocarcinoma in situ and lepidic adenocarcinoma; the former was a more aggressive subtype than the latter. We also showed the relationship between HTR3A expression and Ki-67 positivity, widely used as a proliferation marker. Moreover, we generated HTR3A-knockdown lung adenocarcinoma cells and showed that the HTR3A knockdown attenuated proliferation by ERK phosphorylation. Our results indicated that HTR3A expression was related to proliferation in lung adenocarcinoma, by means of both in vitro and immunohistochemical assays on clinical samples. We showed the therapeutic potential of a 5-HT3 receptor antagonist, tropisetron, for the treatment of lung adenocarcinoma.
AuthorsMitsuyo Tone, Shinichiro Tahara, Satoshi Nojima, Daisuke Motooka, Daisuke Okuzaki, Eiichi Morii
JournalCancer science (Cancer Sci) Vol. 111 Issue 10 Pg. 3953-3961 (Oct 2020) ISSN: 1349-7006 [Electronic] England
PMID32736413 (Publication Type: Journal Article)
Copyright© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • HTR3A protein, human
  • Ki-67 Antigen
  • Receptors, Serotonin, 5-HT3
  • Serotonin 5-HT3 Receptor Antagonists
  • Tropisetron
  • EGFR protein, human
  • ErbB Receptors
  • Mitogen-Activated Protein Kinase 3
Topics
  • Adenocarcinoma of Lung (drug therapy, genetics, pathology)
  • Aged
  • Cell Proliferation (drug effects)
  • ErbB Receptors (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (genetics)
  • Gene Knockdown Techniques
  • Humans
  • Ki-67 Antigen (genetics)
  • Male
  • Middle Aged
  • Mitogen-Activated Protein Kinase 3 (genetics)
  • Phosphorylation (drug effects)
  • Prognosis
  • Receptors, Serotonin, 5-HT3 (genetics)
  • Serotonin 5-HT3 Receptor Antagonists (pharmacology)
  • Tropisetron (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: